Alogliptin
Back to searchMolecule Structure
Scientific Name
Alogliptin
Description of the Drug
Alogliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor used to treat hyperglycemia in patients with type 2 diabetes mellitus.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB06203
http://www.drugbank.ca/drugs/DB06203
Brand Name(s)
Vipidia
Company Owner(s)
Takeda Pharmaceuticals Usa Inc
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Dipeptidyl peptidase IV | SINGLE PROTEIN | INHIBITOR | CHEMBL284 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL121028 | ||
| DrugBank | DB06203 | ||
| PubChem: Thomson Pharma | 16549582 | ||
| PubChem | 11450633 | ||
| Nikkaji | J2.587.439K | ||
| PDBe | T22 | ||
| BindingDB | 16285 | ||
| EPA CompTox Dashboard | DTXSID90234130 | ||
| DrugCentral | 4340 | ||
| Brenda | 38639 | ||
| ChemicalBook | CB91011068 | ||
| Guide to Pharmacology | 6319 | ||
| rxnorm | ALOGLIPTIN BENZOATE | ALOGLIPTIN | NESINA |
| ChEBI | 72323 | ||
| ZINC | ZINC000014961096 |
